941 related articles for article (PubMed ID: 1832073)
1. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
2. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
Dexter DT; Jenner P; Schapira AH; Marsden CD
Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
[TBL] [Abstract][Full Text] [Related]
3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
4. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
[TBL] [Abstract][Full Text] [Related]
5. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
6. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
[TBL] [Abstract][Full Text] [Related]
8. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
[TBL] [Abstract][Full Text] [Related]
9. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
Riederer P; Sofic E; Rausch WD; Schmidt B; Reynolds GP; Jellinger K; Youdim MB
J Neurochem; 1989 Feb; 52(2):515-20. PubMed ID: 2911028
[TBL] [Abstract][Full Text] [Related]
10. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
[TBL] [Abstract][Full Text] [Related]
12. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
13. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN
J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558
[TBL] [Abstract][Full Text] [Related]
14. Decreased ferritin levels in brain in Parkinson's disease.
Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
[TBL] [Abstract][Full Text] [Related]
15. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
16. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA
Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660
[TBL] [Abstract][Full Text] [Related]
19. Quantitative susceptibility mapping in atypical Parkinsonisms.
Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
[TBL] [Abstract][Full Text] [Related]
20. Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.
Foroutan P; Murray ME; Fujioka S; Schweitzer KJ; Dickson DW; Wszolek ZK; Grant SC
Radiology; 2013 Jan; 266(1):280-8. PubMed ID: 23151826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
